Overview
Evotec SE is a global drug discovery and development company headquartered in Hamburg, Germany, offering integrated solutions from target-to-clinic, including small molecules, biologics, and cell therapies. They provide expertise in proteomics, metabolomics, chemical biology, and biomarker discovery through sites like Munich. Evotec also supports drug substance manufacturing via Evotec DS in Germany and biologics development through Just – Evotec Biologics.
Frequently asked questions
- What drug discovery capabilities does Evotec offer?
- Evotec provides stand-alone and integrated drug discovery solutions covering target-to-clinic, including chemical biology, proteomics, metabolomics, bioinformatics, and modalities from small molecules to biotherapeutics.
- Where are Evotec's main locations and operations?
- Headquartered in Hamburg, Germany, with key sites in Munich (proteomics center), Neuried, and Halle/Westphalia for drug substance manufacturing; operates 13 sites in Europe and USA with over 3,100 employees worldwide.
- Does Evotec offer manufacturing services for pharma?
- Yes, through Evotec DS (acquired from Central Glass Germany) for clinical and commercial small molecule drug substance manufacturing, and Just – Evotec Biologics for biologics design, development, and manufacturing.